VIC Tech
Fenel is a seasoned executive in the Life Sciences Sector. He was most recently the COO of Cell Signaling Technology, Inc., a privately held Life Sciences company, where he grew the business at a CAGR of 15% over a period of 12 years and provided leadership in the transformation of the company to a global operation. Prior to that, he was the COO of Interleukin Genetics, Inc., a formerly NASDAQ-listed diagnostic company, for 5 years. Prior to Interleukin, he was CFO at LifeCell and Genome Therapeutics, both formerly NASDAQ-listed companies, for a combined period of twelve years. During his professional career, Fenel has scaled up operations, expanded businesses both organically and through strategic partnerships and completed a number of public and private financing transactions. His leadership experience spans various sizes of companies from start-ups to multinationals. Fenel has an MBA and a BA in Business and Finance.
This person is not in the org chart
This person is not in any offices
VIC Tech
VIC is a private, for-profit technology venture development firm in the business of forming new technology companies with the purpose of commercializing licensed technologies, providing an extensive business development team to provide the initial business leadership and other support for the formed companies, and providing management/corporate services to those portfolio companies on a pro-rata cost basis.